BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Wilkoff BL, Hess M, Young J, Abraham WT. Differences in tachyarrhythmia detection and implantable cardioverter defibrillator therapy by primary or secondary prevention indication in cardiac resynchronization therapy patients. J Cardiovasc Electrophysiol. 2004;15:1002-1009. [PMID: 15363071 DOI: 10.1046/j.1540-8167.2004.03625.x] [Cited by in Crossref: 171] [Cited by in F6Publishing: 90] [Article Influence: 10.7] [Reference Citation Analysis]
Number Citing Articles
1 Goldenberg I, Moss AJ. Implantable device therapy. Prog Cardiovasc Dis 2008;50:449-74. [PMID: 18474287 DOI: 10.1016/j.pcad.2007.09.002] [Cited by in Crossref: 16] [Cited by in F6Publishing: 10] [Article Influence: 1.2] [Reference Citation Analysis]
2 Gasparini M, Anselme F, Clementy J, Santini M, Martínez-Ferrer J, De Santo T, Santi E, Schwab JO; ADVANCE CRT-D Investigators. BIVentricular versus right ventricular antitachycardia pacing to terminate ventricular tachyarrhythmias in patients receiving cardiac resynchronization therapy: the ADVANCE CRT-D Trial. Am Heart J 2010;159:1116-1123.e2. [PMID: 20569728 DOI: 10.1016/j.ahj.2010.02.007] [Cited by in Crossref: 39] [Cited by in F6Publishing: 18] [Article Influence: 3.5] [Reference Citation Analysis]
3 León AR, Abraham WT, Curtis AB, Daubert JP, Fisher WG, Gurley J, Hayes DL, Lieberman R, Petersen-stejskal S, Wheelan K. Safety of Transvenous Cardiac Resynchronization System Implantation in Patients With Chronic Heart Failure. Journal of the American College of Cardiology 2005;46:2348-56. [DOI: 10.1016/j.jacc.2005.08.031] [Cited by in Crossref: 183] [Cited by in F6Publishing: 94] [Article Influence: 11.4] [Reference Citation Analysis]
4 Lunati M, Gasparini M, Bocchiardo M, Curnis A, Landolina M, Carboni A, Luzzi G, Zanotto G, Ravazzi P, Magenta G, Denaro A, Distefano P, Grammatico A; on behalf of the InSync ICD Italian Registry Investigators. Clustering of Ventricular Tachyarrhythmias in Heart Failure Patients Implanted with a Biventricular Cardioverter Defibrillator. J Cardiovasc Electrophysiol 2006;17:1299-306. [DOI: 10.1111/j.1540-8167.2006.00618.x] [Cited by in Crossref: 14] [Cited by in F6Publishing: 9] [Article Influence: 0.9] [Reference Citation Analysis]
5 Oosterhoff P, Tereshchenko LG, van der Heyden MA, Ghanem RN, Fetics BJ, Berger RD, Vos MA. Short-term variability of repolarization predicts ventricular tachycardia and sudden cardiac death in patients with structural heart disease: A comparison with QT variability index. Heart Rhythm 2011;8:1584-90. [DOI: 10.1016/j.hrthm.2011.04.033] [Cited by in Crossref: 43] [Cited by in F6Publishing: 25] [Article Influence: 4.3] [Reference Citation Analysis]
6 van der Avoort CJ, Filion KB, Dendukuri N, Brophy JM. Microvolt T-wave alternans as a predictor of mortality and severe arrhythmias in patients with left-ventricular dysfunction: a systematic review and meta-analysis. BMC Cardiovasc Disord 2009;9:5. [PMID: 19175926 DOI: 10.1186/1471-2261-9-5] [Cited by in Crossref: 13] [Cited by in F6Publishing: 8] [Article Influence: 1.1] [Reference Citation Analysis]
7 Wilkoff BL, Williamson BD, Stern RS, Moore SL, Lu F, Lee SW, Birgersdotter-green UM, Wathen MS, Van Gelder IC, Heubner BM, Brown ML, Holloman KK. Strategic Programming of Detection and Therapy Parameters in Implantable Cardioverter-Defibrillators Reduces Shocks in Primary Prevention Patients. Journal of the American College of Cardiology 2008;52:541-50. [DOI: 10.1016/j.jacc.2008.05.011] [Cited by in Crossref: 421] [Cited by in F6Publishing: 231] [Article Influence: 32.4] [Reference Citation Analysis]
8 Triantafyllou S, Katsanos AH, Dilaveris P, Giannopoulos G, Kossyvakis C, Adreanides E, Liantinioti C, Tympas K, Zompola C, Theodorou A, Palaiodimou L, Flevari P, Kosmidou M, Voumvourakis K, Parissis J, Deftereos S, Tsivgoulis G. Implantable Cardiac Monitoring in the Secondary Prevention of Cryptogenic Stroke. Ann Neurol 2020;88:946-55. [PMID: 32827232 DOI: 10.1002/ana.25886] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 3.0] [Reference Citation Analysis]
9 Sotiriou P, Kouidi E, Karagiannis A, Koutlianos N, Geleris P, Vassilikos V, Deligiannis A. Arterial adaptations in athletes of dynamic and static sports disciplines - a pilot study. Clin Physiol Funct Imaging 2019;39:183-91. [PMID: 30417605 DOI: 10.1111/cpf.12554] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
10 Huang YQ, Liu L, Yu YL, Lo K, Chen CL, Huang JY, Zhou YL, Feng YQ. The relationship between famine exposure in early life and left atrial enlargement in adulthood. J Hum Nutr Diet 2021;34:356-64. [PMID: 32830406 DOI: 10.1111/jhn.12802] [Reference Citation Analysis]
11 Markowitz SM, Lewen JM, Wiggenhorn CJ, Abraham WT, Stein KM, Iwai S, Lerman BB. Relationship of Reverse Anatomical Remodeling and Ventricular Arrhythmias After Cardiac Resynchronization. Journal of Cardiovascular Electrophysiology 2009;20:293-8. [DOI: 10.1111/j.1540-8167.2008.01317.x] [Cited by in Crossref: 58] [Cited by in F6Publishing: 32] [Article Influence: 4.5] [Reference Citation Analysis]
12 Peterson PN, Greenlee RT, Go AS, Magid DJ, Cassidy-Bushrow A, Garcia-Montilla R, Glenn KA, Gurwitz JH, Hammill SC, Hayes J, Kadish A, Reynolds K, Sharma P, Smith DH, Varosy PD, Vidaillet H, Zeng CX, Normand ST, Masoudi FA. Comparison of Inappropriate Shocks and Other Health Outcomes Between Single- and Dual-Chamber Implantable Cardioverter-Defibrillators for Primary Prevention of Sudden Cardiac Death: Results From the Cardiovascular Research Network Longitudinal Study of Implantable Cardioverter-Defibrillators. J Am Heart Assoc 2017;6:e006937. [PMID: 29122811 DOI: 10.1161/JAHA.117.006937] [Cited by in Crossref: 9] [Cited by in F6Publishing: 4] [Article Influence: 2.3] [Reference Citation Analysis]
13 Theuns DA, Schaer BA, Soliman OI, Altmann D, Sticherling C, Geleijnse ML, Osswald S, Jordaens L. The prognosis of implantable defibrillator patients treated with cardiac resynchronization therapy: comorbidity burden as predictor of mortality. Europace 2011;13:62-9. [PMID: 20833692 DOI: 10.1093/europace/euq328] [Cited by in Crossref: 55] [Cited by in F6Publishing: 39] [Article Influence: 5.0] [Reference Citation Analysis]
14 Coccina F, Pierdomenico AM, Pizzicannella J, Ianni U, Bufano G, Madonna R, Trubiani O, Cipollone F, Pierdomenico SD. Prognostic value of daytime and nighttime blood pressure in treated hypertensive patients according to age and sex. J Clin Hypertens (Greenwich) 2020;22:2014-21. [PMID: 33459489 DOI: 10.1111/jch.14028] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
15 Sweeney MO, Wathen MS, Volosin K, Abdalla I, Degroot PJ, Otterness MF, Stark AJ. Appropriate and Inappropriate Ventricular Therapies, Quality of Life, and Mortality Among Primary and Secondary Prevention Implantable Cardioverter Defibrillator Patients: Results From the Pacing Fast VT REduces Shock ThErapies (PainFREE Rx II) Trial. Circulation 2005;111:2898-905. [DOI: 10.1161/circulationaha.104.526673] [Cited by in Crossref: 227] [Cited by in F6Publishing: 36] [Article Influence: 14.2] [Reference Citation Analysis]
16 O'callaghan EL, Lataro RM, Roloff EL, Chauhan AS, Salgado HC, Duncan E, Nogaret A, Paton JFR. Enhancing respiratory sinus arrhythmia increases cardiac output in rats with left ventricular dysfunction. J Physiol 2020;598:455-71. [DOI: 10.1113/jp277293] [Cited by in Crossref: 5] [Article Influence: 2.5] [Reference Citation Analysis]
17 Saxon LA, Bristow MR, Boehmer J, Krueger S, Kass DA, De Marco T, Carson P, Dicarlo L, Feldman AM, Galle E, Ecklund F. Predictors of Sudden Cardiac Death and Appropriate Shock in the Comparison of Medical Therapy, Pacing, and Defibrillation in Heart Failure (COMPANION) Trial. Circulation 2006;114:2766-72. [DOI: 10.1161/circulationaha.106.642892] [Cited by in Crossref: 210] [Cited by in F6Publishing: 50] [Article Influence: 14.0] [Reference Citation Analysis]
18 Filion KB, Xie X, van der Avoort CJ, Dendukuri N, Brophy JM. Microvolt T-wave alternans and the selective use of implantable cardioverter defibrillators for primary prevention: A cost-effectiveness study. Int J Technol Assess Health Care 2009;25:151-60. [DOI: 10.1017/s0266462309090205] [Cited by in Crossref: 5] [Article Influence: 0.4] [Reference Citation Analysis]
19 Chen J, Johnson G, Hellkamp AS, Anderson J, Mark DB, Lee KL, Bardy GH, Poole JE. Rapid-rate nonsustained ventricular tachycardia found on implantable cardioverter-defibrillator interrogation: relationship to outcomes in the SCD-HeFT (Sudden Cardiac Death in Heart Failure Trial). J Am Coll Cardiol 2013;61:2161-8. [PMID: 23541974 DOI: 10.1016/j.jacc.2013.02.046] [Cited by in Crossref: 44] [Cited by in F6Publishing: 28] [Article Influence: 5.5] [Reference Citation Analysis]
20 Epstein AE, DiMarco JP, Ellenbogen KA, Estes NA, Freedman RA, Gettes LS, Gillinov AM, Gregoratos G, Hammill SC, Hayes DL. ACC/AHA/HRS 2008 Guidelines for Device-Based Therapy of Cardiac Rhythm Abnormalities: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Revise the ACC/AHA/NASPE 2002 Guideline Update for Implantation of Cardiac Pacemakers and Antiarrhythmia Devices) developed in collaboration with the American Association for Thoracic Surgery and Society of Thoracic Surgeons. J Am Coll Cardiol. 2008;51:e1-62. [PMID: 18498951 DOI: 10.1016/j.jacc.2008.02.032] [Cited by in Crossref: 1144] [Cited by in F6Publishing: 663] [Article Influence: 88.0] [Reference Citation Analysis]
21 Gasparini M, Menozzi C, Proclemer A, Landolina M, Iacopino S, Carboni A, Lombardo E, Regoli F, Biffi M, Burrone V, Denaro A, Boriani G. A simplified biventricular defibrillator with fixed long detection intervals reduces implantable cardioverter defibrillator (ICD) interventions and heart failure hospitalizations in patients with non-ischaemic cardiomyopathy implanted for primary prevention: the RELEVANT [Role of long dEtection window programming in patients with LEft VentriculAr dysfunction, Non-ischemic eTiology in primary prevention treated with a biventricular ICD] study. Eur Heart J 2009;30:2758-67. [PMID: 19567380 DOI: 10.1093/eurheartj/ehp247] [Cited by in Crossref: 119] [Cited by in F6Publishing: 69] [Article Influence: 9.9] [Reference Citation Analysis]
22 Shitara J, Kasai T, Murata N, Yamakawa N, Yatsu S, Murata A, Matsumoto H, Kato T, Suda S, Matsue Y, Naito R, Hiki M, Daida H. Temporal changes of cardiac acoustic biomarkers and cardiac function in acute decompensated heart failure. ESC Heart Fail 2021. [PMID: 34184415 DOI: 10.1002/ehf2.13492] [Reference Citation Analysis]
23 Voelkel NF, Natarajan R, Drake JI, Bogaard HJ. Right ventricle in pulmonary hypertension. Compr Physiol 2011;1:525-40. [PMID: 23737184 DOI: 10.1002/cphy.c090008] [Cited by in Crossref: 8] [Cited by in F6Publishing: 15] [Article Influence: 1.0] [Reference Citation Analysis]
24 Chen Z, Kotecha T, Crichton S, Shetty A, Sohal M, Arujuna A, Kirubakaran S, Bostock J, Cooklin M, O'Neill M, Wright M, Gill JS, Rinaldi CA. Lower incidence of inappropriate shock therapy in patients with combined cardiac resynchronisation therapy defibrillators (CRT-D) compared with patients with non-CRT defibrillators (ICDs). Int J Clin Pract 2013;67:733-9. [PMID: 23869676 DOI: 10.1111/ijcp.12033] [Cited by in Crossref: 11] [Cited by in F6Publishing: 5] [Article Influence: 1.6] [Reference Citation Analysis]
25 Sweeney MO. Troubleshooting of Biventricular Devices. Clinical Cardiac Pacing, Defibrillation and Resynchronization Therapy. Elsevier; 2011. pp. 911-86. [DOI: 10.1016/b978-1-4377-1616-0.00031-x] [Cited by in Crossref: 2] [Article Influence: 0.2] [Reference Citation Analysis]
26 Swerdlow CD, Russo AM, Degroot PJ. The dilemma of ICD implant testing. Pacing Clin Electrophysiol. 2007;30:675-700. [PMID: 17461879 DOI: 10.1111/j.1540-8159.2007.00730.x] [Cited by in Crossref: 112] [Cited by in F6Publishing: 59] [Article Influence: 8.0] [Reference Citation Analysis]
27 Webber MR, Stiles MK. Recommendations for the Programming of Implantable Cardioverter-Defibrillators in New Zealand. Heart, Lung and Circulation 2012;21:765-77. [DOI: 10.1016/j.hlc.2012.07.017] [Cited by in Crossref: 10] [Cited by in F6Publishing: 6] [Article Influence: 1.1] [Reference Citation Analysis]
28 Tereshchenko LG, Henrikson CA, Stempniewicz P, Han L, Berger RD. Antiarrhythmic Effect of Reverse Electrical Remodeling Associated with Cardiac Resynchronization Therapy: REVERSE ELECTRICAL REMODELING. Pacing and Clinical Electrophysiology 2011;34:357-64. [DOI: 10.1111/j.1540-8159.2010.02974.x] [Cited by in Crossref: 19] [Cited by in F6Publishing: 8] [Article Influence: 1.7] [Reference Citation Analysis]
29 Cho SKS, Darby JRT, Saini BS, Lock MC, Holman SL, Lim JM, Perumal SR, Macgowan CK, Morrison JL, Seed M. Feasibility of ventricular volumetry by cardiovascular MRI to assess cardiac function in the fetal sheep. J Physiol 2020;598:2557-73. [PMID: 32378201 DOI: 10.1113/JP279054] [Cited by in Crossref: 6] [Cited by in F6Publishing: 2] [Article Influence: 6.0] [Reference Citation Analysis]
30 Apiyasawat S, Sahasthas D, Ngarmukos T, Chandanamattha P, Likittanasombat K. Fragmented QRS as a Predictor of Appropriate Implantable Cardioverter-defibrillator Therapy. Indian Pacing Electrophysiol J 2014;14:4-11. [PMID: 24493911 DOI: 10.1016/s0972-6292(16)30710-0] [Cited by in Crossref: 6] [Cited by in F6Publishing: 1] [Article Influence: 0.9] [Reference Citation Analysis]
31 Buddeberg BS, Sharma R, O'Driscoll JM, Kaelin Agten A, Khalil A, Thilaganathan B. Cardiac maladaptation in obese pregnant women at term. Ultrasound Obstet Gynecol 2019;54:344-9. [PMID: 30381850 DOI: 10.1002/uog.20170] [Cited by in Crossref: 10] [Cited by in F6Publishing: 8] [Article Influence: 10.0] [Reference Citation Analysis]
32 Saxon LA, Hayes DL, Gilliam FR, Heidenreich PA, Day J, Seth M, Meyer TE, Jones PW, Boehmer JP. Long-term outcome after ICD and CRT implantation and influence of remote device follow-up: the ALTITUDE survival study. Circulation 2010;122:2359-67. [PMID: 21098452 DOI: 10.1161/CIRCULATIONAHA.110.960633] [Cited by in Crossref: 370] [Cited by in F6Publishing: 73] [Article Influence: 33.6] [Reference Citation Analysis]
33 Klein G, Lissel C, Fuchs A, Gardiwal A, Oswald H, deSousa M, Pichlmaier AM, Lichtinghagen R, Geerlings H, Lippolt P, Niehaus M, Drexler H, Korte T. Predictors of VT/VF-occurrence in ICD patients: results from the PROFIT-Study. EP Europace 2006;8:618-24. [DOI: 10.1093/europace/eul082] [Cited by in Crossref: 44] [Cited by in F6Publishing: 24] [Article Influence: 2.9] [Reference Citation Analysis]
34 Kocabaş U, Payzın S, Hasdemir C. Assessment of atrial functional remodeling in patients with atrioventricular nodal reentrant tachycardia with and without drug-induced type 1 Brugada pattern: A case-control study. J Clin Ultrasound 2021;49:573-9. [PMID: 33599988 DOI: 10.1002/jcu.22990] [Reference Citation Analysis]
35 Nordbeck P, Seidl B, Fey B, Bauer WR, Ritter O. Effect of cardiac resynchronization therapy on the incidence of electrical storm. Int J Cardiol. 2010;143:330-336. [PMID: 19359057 DOI: 10.1016/j.ijcard.2009.03.055] [Cited by in Crossref: 20] [Cited by in F6Publishing: 9] [Article Influence: 1.7] [Reference Citation Analysis]
36 Hreybe H, Bedi M, Ezzeddine R, Barrington W, Jain S, Ngwu O, Saba S. Indications for internal cardioverter defibrillator implantation predict time to first shock and the modulating effect of β-blockers. American Heart Journal 2005;150:1064.e1-5. [DOI: 10.1016/j.ahj.2005.07.019] [Cited by in Crossref: 16] [Cited by in F6Publishing: 8] [Article Influence: 1.0] [Reference Citation Analysis]
37 Sweeney MO. The Nature of the Game. J Cardiovasc Electrophysiol 2005;16:483-5. [DOI: 10.1111/j.1540-8167.2005.40853.x] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 0.3] [Reference Citation Analysis]
38 Friedman PA, Bradley D, Koestler C, Slusser J, Hodge D, Bailey K, Kusumoto F, Munger TM, Militanu A, Glikson M. A prospective randomized trial of single- or dual-chamber implantable cardioverter-defibrillators to minimize inappropriate shock risk in primary sudden cardiac death prevention. Europace 2014;16:1460-8. [DOI: 10.1093/europace/euu022] [Cited by in Crossref: 27] [Cited by in F6Publishing: 14] [Article Influence: 3.9] [Reference Citation Analysis]
39 Valenzuela-Alcaraz B, Serafini A, Sepulveda-Martínez A, Casals G, Rodríguez-López M, Garcia-Otero L, Cruz-Lemini M, Bijnens B, Sitges M, Balasch J, Gratacós E, Crispi F. Postnatal persistence of fetal cardiovascular remodelling associated with assisted reproductive technologies: a cohort study. BJOG 2019;126:291-8. [PMID: 29673050 DOI: 10.1111/1471-0528.15246] [Cited by in Crossref: 16] [Cited by in F6Publishing: 9] [Article Influence: 5.3] [Reference Citation Analysis]
40 Laish-Farkash A, Perelshtein Brezinov O, Valdman A, Tam D, Rahkovich M, Kogan Y, Marincheva G. Evaluation of left atrial remodeling by 2D-speckle-tracking echocardiography versus by high-density voltage mapping in patients with atrial fibrillation. J Cardiovasc Electrophysiol 2021;32:305-15. [PMID: 33331056 DOI: 10.1111/jce.14837] [Reference Citation Analysis]
41 Chung MK. The Role of the Wearable Cardioverter Defibrillator in Clinical Practice. Cardiology Clinics 2014;32:253-70. [DOI: 10.1016/j.ccl.2013.11.002] [Cited by in Crossref: 26] [Cited by in F6Publishing: 18] [Article Influence: 3.7] [Reference Citation Analysis]
42 Kutyifa V, Vermilye K, Solomon SD, McNitt S, Moss AJ, Daimee UA. Long-term outcomes of cardiac resynchronization therapy by left ventricular ejection fraction. Eur J Heart Fail 2019;21:360-9. [PMID: 30592353 DOI: 10.1002/ejhf.1357] [Cited by in Crossref: 5] [Cited by in F6Publishing: 2] [Article Influence: 1.7] [Reference Citation Analysis]
43 Wilkoff BL, Ousdigian KT, Sterns LD, Wang ZJ, Wilson RD, Morgan JM. A comparison of empiric to physician-tailored programming of implantable cardioverter-defibrillators: results from the prospective randomized multicenter EMPIRIC trial. J Am Coll Cardiol. 2006;48:330-339. [PMID: 16843184 DOI: 10.1016/j.jacc.2006.03.037] [Cited by in Crossref: 192] [Cited by in F6Publishing: 106] [Article Influence: 12.8] [Reference Citation Analysis]
44 Weiss R, Knight BP, Gold MR, Leon AR, Herre JM, Hood M, Rashtian M, Kremers M, Crozier I, Lee KL, Smith W, Burke MC. Safety and Efficacy of a Totally Subcutaneous Implantable-Cardioverter Defibrillator. Circulation 2013;128:944-53. [DOI: 10.1161/circulationaha.113.003042] [Cited by in Crossref: 366] [Cited by in F6Publishing: 66] [Article Influence: 45.8] [Reference Citation Analysis]
45 Israel CW. How to avoid inappropriate therapy. Current Opinion in Cardiology 2008;23:65-71. [DOI: 10.1097/hco.0b013e3282f30436] [Cited by in Crossref: 12] [Cited by in F6Publishing: 1] [Article Influence: 0.9] [Reference Citation Analysis]
46 Grimm W, Plachta E, Maisch B. Antitachycardia Pacing for Spontaneous Rapid Ventricular Tachycardia in Patients with Prophylactic Cardioverter-Defibrillator Therapy. Pacing Clin Electro 2006;29:759-64. [DOI: 10.1111/j.1540-8159.2006.00431.x] [Cited by in Crossref: 31] [Cited by in F6Publishing: 18] [Article Influence: 2.1] [Reference Citation Analysis]
47 Theuns DA, Thornton AS, Klootwijk APJ, Scholten MF, Vantrimpont PJ, Balk AH, Jordaens LJ. Outcome in patients with an ICD incorporating cardiac resynchronisation therapy: Differences between primary and secondary prophylaxis. European Journal of Heart Failure 2005;7:1027-32. [DOI: 10.1016/j.ejheart.2005.05.006] [Cited by in Crossref: 12] [Cited by in F6Publishing: 5] [Article Influence: 0.9] [Reference Citation Analysis]
48 Gasparini M, Lunati M, Landolina M, Santini M, Padeletti L, Perego G, Vincenti A, Curnis A, Carboni A, Denaro A. Electrical storm in patients with biventricular implantable cardioverter defibrillator: incidence, predictors, and prognostic implications. Am Heart J. 2008;156:847-854. [PMID: 19061697 DOI: 10.1016/j.ahj.2008.06.035] [Cited by in Crossref: 17] [Cited by in F6Publishing: 10] [Article Influence: 1.3] [Reference Citation Analysis]
49 Miyauchi S, Tokuyama T, Shintani T, Nishi H, Hamamoto Y, Ouhara K, Furusho H, Miyauchi M, Komatsuzawa H, Nakano Y. Periodontitis and the outcome of atrial fibrillation ablation: Porphyromonas gingivalis is related to atrial fibrillation recurrence. J Cardiovasc Electrophysiol 2021;32:1240-50. [PMID: 33590642 DOI: 10.1111/jce.14952] [Reference Citation Analysis]
50 Germano JJ, Reynolds M, Essebag V, Josephson ME. Frequency and causes of implantable cardioverter-defibrillator therapies: is device therapy proarrhythmic? Am J Cardiol. 2006;97:1255-1261. [PMID: 16616037 DOI: 10.1016/j.amjcard.2005.11.048] [Cited by in Crossref: 168] [Cited by in F6Publishing: 113] [Article Influence: 11.2] [Reference Citation Analysis]
51 Hao G, Wang X, Chen Z, Zhang L, Zhang Y, Wei B, Zheng C, Kang Y, Jiang L, Zhu Z, Zhang J, Wang Z, Gao R; China Hypertension Survey Investigators. Prevalence of heart failure and left ventricular dysfunction in China: the China Hypertension Survey, 2012-2015. Eur J Heart Fail 2019;21:1329-37. [PMID: 31746111 DOI: 10.1002/ejhf.1629] [Cited by in Crossref: 28] [Cited by in F6Publishing: 12] [Article Influence: 28.0] [Reference Citation Analysis]
52 Cruzado JM, Pascual J, Sánchez‐fructuoso A, Serón D, Díaz JM, Rengel M, Oppenheimer F, Hernández D, Paravisini A, Saval N, Morales JM; Evita Study Group. Controlled randomized study comparing the cardiovascular profile of everolimus with tacrolimus in renal transplantation. Transpl Int 2016;29:1317-28. [DOI: 10.1111/tri.12862] [Cited by in Crossref: 10] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
53 Ozde C, Dogru M, Ozde Ş, Kayapinar O, Kaya A, Korkmaz A. Subclinical right ventricular dysfunction in intermittent and persistent mildly asthmatic children on tissue Doppler echocardiography and serum NT-proBNP: Observational study. Pediatr Int 2018;60:1024-32. [PMID: 30179288 DOI: 10.1111/ped.13689] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
54 Ruwald MH, Ruwald AC, Johansen JB, Gislason G, Lindhardt TB, Nielsen JC, Torp-Pedersen C, Riahi S, Vinther M, Philbert BT. Temporal Incidence of Appropriate and Inappropriate Therapy and Mortality in Secondary Prevention ICD Patients by Cardiac Diagnosis. JACC Clin Electrophysiol 2021;7:781-92. [PMID: 33516705 DOI: 10.1016/j.jacep.2020.11.005] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
55 Cakulev I, Mackall JA. One size fits all, or do we have to rethink optimal programming in implantable cardioverter-defibrillators implanted for secondary prevention? Heart Rhythm O2 2020;1:83-4. [PMID: 34115051 DOI: 10.1016/j.hroo.2020.05.001] [Reference Citation Analysis]
56 Boriani G, Gasparini M, Lunati M, Santini M, Landolina M, Vincenti A, Curnis A, Bocchiardo M, Padeletti L, Biffi M, Allaria L, Denaro A. Characteristics of ventricular tachyarrhythmias occurring in ischemic versus nonischemic patients implanted with a biventricular cardioverter-defibrillator for primary or secondary prevention of sudden death. American Heart Journal 2006;152:527.e1-527.e11. [DOI: 10.1016/j.ahj.2006.03.003] [Cited by in Crossref: 9] [Cited by in F6Publishing: 7] [Article Influence: 0.6] [Reference Citation Analysis]
57 Madhavan M, Friedman PA. Optimal Programming of Implantable Cardiac-Defibrillators. Circulation 2013;128:659-72. [DOI: 10.1161/circulationaha.112.000542] [Cited by in Crossref: 32] [Cited by in F6Publishing: 4] [Article Influence: 4.0] [Reference Citation Analysis]
58 LaBounty TM, Bach DS, Bossone E, Kolias TJ. Indexing left ventricular wall thickness to body surface area improves prognostic value. Echocardiography 2019;36:824-30. [PMID: 30905085 DOI: 10.1111/echo.14317] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.5] [Reference Citation Analysis]
59 Suursalmi P, Eerola A, Poutanen T, Korhonen P, Kopeli T, Tammela O. Very low birthweight bronchopulmonary dysplasia survivors had similar cardiac outcomes to controls at six years to 14 years of age. Acta Paediatr 2017;106:261-7. [DOI: 10.1111/apa.13647] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.4] [Reference Citation Analysis]
60 Yap S, Schaer BA, Bhagwandien RE, Kühne M, Dabiri Abkenari L, Osswald S, Szili-torok T, Sticherling C, Theuns DAMJ. Evaluation of the need of elective implantable cardioverter-defibrillator generator replacement in primary prevention patients without prior appropriate ICD therapy. Heart 2014;100:1188-92. [DOI: 10.1136/heartjnl-2014-305535] [Cited by in Crossref: 24] [Cited by in F6Publishing: 16] [Article Influence: 3.4] [Reference Citation Analysis]
61 van Welsenes GH, van Rees JB, Borleffs CJW, Cannegieter SC, Bax JJ, van Erven L, Schalij MJ. Long-term follow-up of primary and secondary prevention implantable cardioverter defibrillator patients. Europace 2011;13:389-94. [DOI: 10.1093/europace/euq494] [Cited by in Crossref: 69] [Cited by in F6Publishing: 41] [Article Influence: 6.9] [Reference Citation Analysis]
62 Epstein AE, DiMarco JP, Ellenbogen KA, Estes NA, Freedman RA, Gettes LS, Gillinov AM, Gregoratos G, Hammill SC, Hayes DL, Hlatky MA, Newby LK, Page RL, Schoenfeld MH, Silka MJ, Stevenson LW, Sweeney MO, Tracy CM, Epstein AE, Darbar D, DiMarco JP, Dunbar SB, Estes NA, Ferguson TB, Hammill SC, Karasik PE, Link MS, Marine JE, Schoenfeld MH, Shanker AJ, Silka MJ, Stevenson LW, Stevenson WG, Varosy PD; American College of Cardiology Foundation; American Heart Association Task Force on Practice Guidelines; Heart Rhythm Society. 2012 ACCF/AHA/HRS focused update incorporated into the ACCF/AHA/HRS 2008 guidelines for device-based therapy of cardiac rhythm abnormalities: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines and the Heart Rhythm Society. J Am Coll Cardiol. 2013;61:e6-75. [PMID: 23265327 DOI: 10.1016/j.jacc.2012.11.007] [Cited by in Crossref: 419] [Cited by in F6Publishing: 253] [Article Influence: 46.6] [Reference Citation Analysis]
63 Lewis GF, Gold MR. Safety and Efficacy of the Subcutaneous Implantable Defibrillator. Journal of the American College of Cardiology 2016;67:445-54. [DOI: 10.1016/j.jacc.2015.11.026] [Cited by in Crossref: 41] [Cited by in F6Publishing: 16] [Article Influence: 8.2] [Reference Citation Analysis]
64 Shah BK. Optimal Implantable Cardioverter Defibrillator Programming. Cardiol Rev 2017;25:30-5. [PMID: 27922468 DOI: 10.1097/CRD.0000000000000133] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
65 Gassis S, Le AR. Cardiac Resynchronization Therapy: Strategies for Device Programming, Troubleshooting and Follow-Up. J Interv Card Electrophysiol 2005;13:209-22. [DOI: 10.1007/s10840-005-3247-9] [Cited by in Crossref: 11] [Cited by in F6Publishing: 5] [Article Influence: 0.7] [Reference Citation Analysis]
66 Wilkoff BL, Stern R, Williamson B, Wathen M, Holloman K, Fieberg A, Brown M. Design of the Primary Prevention Parameters Evaluation (PREPARE) trial of implantable cardioverter defibrillators to reduce patient morbidity [NCT00279279]. Trials 2006;7:18. [PMID: 16725036 DOI: 10.1186/1745-6215-7-18] [Cited by in Crossref: 12] [Cited by in F6Publishing: 7] [Article Influence: 0.8] [Reference Citation Analysis]
67 Auricchio A, Meijer A, Kurita T, Schloss E, Brinkman K, Claessens-van Ooijen M, Sterns L. Safety, efficacy, and performance of new discrimination algorithms to reduce inappropriate and unnecessary shocks: the PainFree SST clinical study design. Europace 2011;13:1484-93. [DOI: 10.1093/europace/eur133] [Cited by in Crossref: 25] [Cited by in F6Publishing: 7] [Article Influence: 2.5] [Reference Citation Analysis]
68 Epstein AE, DiMarco JP, Ellenbogen KA, Estes NA, Freedman RA, Gettes LS, Gillinov AM, Gregoratos G, Hammill SC, Hayes DL. ACC/AHA/HRS 2008 Guidelines for Device-Based Therapy of Cardiac Rhythm Abnormalities: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Revise the ACC/AHA/NASPE 2002 Guideline Update for Implantation of Cardiac Pacemakers and Antiarrhythmia Devices): developed in collaboration with the American Association for Thoracic Surgery and Society of Thoracic Surgeons. Circulation. 2008;117:e350-e408. [PMID: 18483207 DOI: 10.1161/circualtionaha.108.189742] [Cited by in Crossref: 784] [Cited by in F6Publishing: 218] [Article Influence: 60.3] [Reference Citation Analysis]
69 Epstein AE, DiMarco JP, Ellenbogen KA, Estes NA, Freedman RA, Gettes LS, Gillinov AM, Gregoratos G, Hammill SC, Hayes DL. 2012 ACCF/AHA/HRS focused update incorporated into the ACCF/AHA/HRS 2008 guidelines for device-based therapy of cardiac rhythm abnormalities: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines and the Heart Rhythm Society. Circulation. 2013;127:e283-e352. [PMID: 23255456 DOI: 10.1161/cir.0b013e318276ce9b] [Cited by in Crossref: 363] [Cited by in F6Publishing: 110] [Article Influence: 40.3] [Reference Citation Analysis]
70 Freedberg NA, Feldman A. Prognostic Significance of Implantable Defibrillator Shock: Are All Shocks Created Equal? Journal of Cardiovascular Electrophysiology 2012;23:741-3. [DOI: 10.1111/j.1540-8167.2012.02299.x] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.2] [Reference Citation Analysis]
71 Daubert JP, Zareba W, Cannom DS, McNitt S, Rosero SZ, Wang P, Schuger C, Steinberg JS, Higgins SL, Wilber DJ, Klein H, Andrews ML, Hall WJ, Moss AJ;  MADIT II Investigators. Inappropriate implantable cardioverter-defibrillator shocks in MADIT II: frequency, mechanisms, predictors, and survival impact. J Am Coll Cardiol. 2008;51:1357-1365. [PMID: 18387436 DOI: 10.1016/j.jacc.2007.09.073] [Cited by in Crossref: 585] [Cited by in F6Publishing: 322] [Article Influence: 45.0] [Reference Citation Analysis]
72 Saeed M, Neason CG, Razavi M, Chandiramani S, Alonso J, Natarajan S, Ip JH, Peress DF, Ramadas S, Massumi A. Programming Antitachycardia Pacing for Primary Prevention in Patients With Implantable Cardioverter Defibrillators: Results From the PROVE Trial. Journal of Cardiovascular Electrophysiology 2010;21:1349-54. [DOI: 10.1111/j.1540-8167.2010.01825.x] [Cited by in Crossref: 38] [Cited by in F6Publishing: 25] [Article Influence: 3.5] [Reference Citation Analysis]
73 Callum K, Graune C, Bowman E, Molden E, Leslie SJ. Remote monitoring of implantable defibrillators is associated with fewer inappropriate shocks and reduced time to medical assessment in a remote and rural area. World J Cardiol 2021;13:46-54. [PMID: 33791078 DOI: 10.4330/wjc.v13.i3.46] [Reference Citation Analysis]
74 Ricci RP, Pignalberi C, Landolina M, Santini M, Lunati M, Boriani G, Proclemer A, Facchin D, Catanzariti D, Morani G, Gulizia M, Mangoni L, Grammatico A, Gasparini M; on behalf of the ClinicalService cardiological centres. Ventricular rate monitoring as a tool to predict and prevent atrial fibrillation-related inappropriate shocks in heart failure patients treated with cardiac resynchronisation therapy defibrillators. Heart 2014;100:848-54. [DOI: 10.1136/heartjnl-2013-305259] [Cited by in Crossref: 6] [Cited by in F6Publishing: 2] [Article Influence: 0.9] [Reference Citation Analysis]
75 An SM, Nam JS, Kim HJ, Bae HJ, Chin JH, Lee EH, Choi IC. Postoperative changes in left ventricular systolic function after combined mitral and aortic valve replacement in patients with rheumatic heart disease. J Card Surg 2021. [PMID: 34252984 DOI: 10.1111/jocs.15814] [Reference Citation Analysis]
76 Tan TC, Neilan TG, Francis S, Plana JC, Scherrer-Crosbie M. Anthracycline-Induced Cardiomyopathy in Adults. Compr Physiol 2015;5:1517-40. [PMID: 26140726 DOI: 10.1002/cphy.c140059] [Cited by in Crossref: 34] [Cited by in F6Publishing: 19] [Article Influence: 6.8] [Reference Citation Analysis]
77 Alhakak AS, Sengeløv M, Jørgensen PG, Bruun NE, Johnsen C, Abildgaard U, Iversen AZ, Hansen TF, Teerlink JR, Malik FI, Solomon SD, Gislason G, Biering-Sørensen T. Left ventricular systolic ejection time is an independent predictor of all-cause mortality in heart failure with reduced ejection fraction. Eur J Heart Fail 2021;23:240-9. [PMID: 33034122 DOI: 10.1002/ejhf.2022] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 5.0] [Reference Citation Analysis]
78 Gulizia MM, Piraino L, Scherillo M, Puntrello C, Vasco C, Scianaro MC, Mascia F, Pensabene O, Giglia S, Chiarandà G, Vaccaro I, Mangiameli S, Corrao D, Santi E, Grammatico A; PITAGORA ICD Study Investigators. A randomized study to compare ramp versus burst antitachycardia pacing therapies to treat fast ventricular tachyarrhythmias in patients with implantable cardioverter defibrillators: the PITAGORA ICD trial. Circ Arrhythm Electrophysiol 2009;2:146-53. [PMID: 19808459 DOI: 10.1161/CIRCEP.108.804211] [Cited by in Crossref: 55] [Cited by in F6Publishing: 11] [Article Influence: 4.6] [Reference Citation Analysis]
79 Khairy P, Mansour F. Implantable cardioverter-defibrillators in congenital heart disease: 10 programming tips. Heart Rhythm 2011;8:480-3. [DOI: 10.1016/j.hrthm.2010.10.046] [Cited by in Crossref: 20] [Cited by in F6Publishing: 15] [Article Influence: 2.0] [Reference Citation Analysis]
80 Tzeis S, Andrikopoulos G, Kolb C, Vardas PE. Tools and strategies for the reduction of inappropriate implantable cardioverter defibrillator shocks. Europace 2008;10:1256-65. [PMID: 18708639 DOI: 10.1093/europace/eun205] [Cited by in Crossref: 21] [Cited by in F6Publishing: 17] [Article Influence: 1.6] [Reference Citation Analysis]
81 Fischer A, Ousdigian KT, Johnson JW, Gillberg JM, Wilkoff BL. The impact of atrial fibrillation with rapid ventricular rates and device programming on shocks in 106,513 ICD and CRT-D patients. Heart Rhythm 2012;9:24-31. [DOI: 10.1016/j.hrthm.2011.08.005] [Cited by in Crossref: 41] [Cited by in F6Publishing: 22] [Article Influence: 4.6] [Reference Citation Analysis]
82 Biering-Sørensen T, Santos M, Rivero J, McCullough SD, West E, Opotowsky AR, Waxman AB, Systrom DM, Shah AM. Left ventricular deformation at rest predicts exercise-induced elevation in pulmonary artery wedge pressure in patients with unexplained dyspnoea. Eur J Heart Fail 2017;19:101-10. [PMID: 27878925 DOI: 10.1002/ejhf.659] [Cited by in Crossref: 20] [Cited by in F6Publishing: 15] [Article Influence: 4.0] [Reference Citation Analysis]
83 Poole JE, Johnson GW, Hellkamp AS, Anderson J, Callans DJ, Raitt MH, Reddy RK, Marchlinski FE, Yee R, Guarnieri T, Talajic M, Wilber DJ, Fishbein DP, Packer DL, Mark DB, Lee KL, Bardy GH. Prognostic importance of defibrillator shocks in patients with heart failure. N Engl J Med. 2008;359:1009-1017. [PMID: 18768944 DOI: 10.1056/nejmoa071098] [Cited by in Crossref: 1015] [Cited by in F6Publishing: 151] [Article Influence: 78.1] [Reference Citation Analysis]
84 Epstein AE, Dimarco JP, Ellenbogen KA, Estes NA, Freedman RA, Gettes LS, Gillinov AM, Gregoratos G, Hammill SC, Hayes DL. ACC/AHA/HRS 2008 Guidelines for device-based therapy of cardiac rhythm abnormalities. Heart Rhythm. 2008;5:e1-62. [PMID: 18534360 DOI: 10.1016/j.hrthm.2008.04.014] [Cited by in Crossref: 208] [Cited by in F6Publishing: 105] [Article Influence: 16.0] [Reference Citation Analysis]
85 Mansour F, Khairy P. Programming ICDs in the Modern Era beyond Out-of-the Box Settings: ICD PROGRAMMING TIPS. Pacing and Clinical Electrophysiology 2011;34:506-20. [DOI: 10.1111/j.1540-8159.2011.03037.x] [Cited by in Crossref: 27] [Cited by in F6Publishing: 14] [Article Influence: 2.7] [Reference Citation Analysis]
86 Zhou Y, Zhao S, Chen K, Hua W, Su Y, Chen S, Liang Z, Xu W, Zhang S. Risk of subsequent ventricular arrhythmia is higher in primary prevention patients with implantable cardioverter defibrillator than in secondary prevention patients. BMC Cardiovasc Disord 2019;19:230. [PMID: 31638918 DOI: 10.1186/s12872-019-1218-9] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
87 Desai AD, Burke MC, Hong TE, Kim S, Salem Y, Yong PG, Knight BP. Predictors of Appropriate Defibrillator Therapy Among Patients with an Implantable Defibrillator That Delivers Cardiac Resynchronization Therapy. J Cardiovasc Electrophysiol 2006;17:486-90. [DOI: 10.1111/j.1540-8167.2006.00355.x] [Cited by in Crossref: 27] [Cited by in F6Publishing: 14] [Article Influence: 1.8] [Reference Citation Analysis]
88 Kloppe A, Proclemer A, Arenal A, Lunati M, Martìnez Ferrer JB, Hersi A, Gulaj M, Wijffels MC, Santi E, Manotta L, Mangoni L, Gasparini M. Efficacy of Long Detection Interval Implantable Cardioverter-Defibrillator Settings in Secondary Prevention Population: Data From the Avoid Delivering Therapies for Nonsustained Arrhythmias in ICD Patients III (ADVANCE III) Trial. Circulation 2014;130:308-14. [DOI: 10.1161/circulationaha.114.009468] [Cited by in Crossref: 57] [Cited by in F6Publishing: 13] [Article Influence: 8.1] [Reference Citation Analysis]
89 Ypenburg C, van Erven L, Bleeker GB, Bax JJ, Bootsma M, Wijffels MC, van der Wall EE, Schalij MJ. Benefit of Combined Resynchronization and Defibrillator Therapy in Heart Failure Patients With and Without Ventricular Arrhythmias. Journal of the American College of Cardiology 2006;48:464-70. [DOI: 10.1016/j.jacc.2006.04.072] [Cited by in Crossref: 23] [Cited by in F6Publishing: 11] [Article Influence: 1.5] [Reference Citation Analysis]